Target intelligence / Profile preview

Influenza virus hemagglutinin stem domain (HA stem)

Target
HA stem
Molecular classification
Viral protein, Glycoprotein, Membrane fusion protein, Receptor-binding protein (via HA1, but stem domain mediates fusion)
01

Overview

The hemagglutinin stem domain is the lower structural portion (stalk) of the hemagglutinin glycoprotein found on the surface of influenza virions. Whereas the head (globe) domain mediates sialic acid receptor binding, the stem is responsible for mediating the conformational changes and membrane fusion events that allow viral entry into host cells after endocytosis. The stem domain contains highly conserved amino acid sequences and structural motifs, making it an attractive target for broad-spectrum influenza therapeutics and "universal vaccine" design, capable of eliciting broadly neutralizing antibodies effective against diverse influenza subtypes. Antibodies binding to the stem block membrane fusion, either directly or through immune effector mechanisms such as antibody-dependent cellular cytotoxicity and complement activation; experimental stem-only immunogens and monoclonal antibodies targeting the stem show broad protective efficacy in animal models and early clinical studies. Major challenges include overcoming immunodominance of the head domain and ensuring proper presentation and stability of the stem for effective vaccine design. This domain does not have a direct "receptor" function but is classified as a membrane fusion protein with critical roles in viral infectivity.

Other names
Hemagglutinin stalk domainHA stemHA2 (hemagglutinin subunit 2)Stalk region of hemagglutinin
02

Mechanism of action

Inhibition of viral membrane fusion by stabilizing prefusion conformation of HA stem; Antibody-dependent cellular cytotoxicity and complement-dependent lysis mediated by stem-targeting antibodies; Neutralization of viral infectivity by blocking conformational changes needed for fusion.

03

Biological functions

Mediates membrane fusion between viral envelope and host cell endosomal membraneEssential for viral entry into host cellsMajor antigenic site for broadly neutralizing antibodies
04

Disease associations

Infection (influenza)Pandemic and seasonal influenza outbreaksTarget for universal influenza vaccine development
05

Safety considerations

Antigenic competition: Immunodominance of HA head may reduce immune response targeting the stemVaccine challenges: Difficulty in designing stable stem-only immunogensPotential for viral escape: Mutational drift or structural rearrangement may confer resistance (though stem is highly conserved)No major toxicity or off-target concerns for antibody therapies observed in clinical trials to date
06

Interacting drugs

None approved small molecules for stem domain specifically

3 more in the full profile.

07

Biomarkers

Presence of stem-targeting broadly neutralizing antibodies (bNAbs) in serumResponse to stem-only immunogens (universal vaccine candidates)No prevalent clinical biomarkers yet for patient selection

Beyond the preview

Go deeper on Influenza virus hemagglutinin stem domain (HA stem).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza virus hemagglutinin stem domain (HA stem).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call